Summary of opinion: Elrexfio,elranatamab, 12/10/2023, Positive
On 12 October 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a conditional1 marketing authorisation for the medicinal product Elrexfio2, intended for the treatment of multiple …